4//SEC Filing
Srinivasan Venkatesh 4
Accession 0001415889-25-011997
CIK 0001382101other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 5:46 PM ET
Size
9.0 KB
Accession
0001415889-25-011997
Insider Transaction Report
Form 4
Srinivasan Venkatesh
CHIEF TECH OP OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-05-01+2,500→ 54,580 total - Tax Payment
Common Stock
2025-05-01$1.07/sh−894$957→ 53,686 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2025-05-01−2,500→ 5,000 totalExp: 2027-05-01→ Common Stock (2,500 underlying)
Footnotes (3)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
- [F2]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F3]The RSUs vest as to 1/4th of the total award annually beginning on May 1, 2024, subject to continued service through each vesting date.
Documents
Issuer
SUTRO BIOPHARMA, INC.
CIK 0001382101
Entity typeother
Related Parties
1- filerCIK 0001974888
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 5:46 PM ET
- Size
- 9.0 KB